<DOC>
	<DOCNO>NCT00971607</DOCNO>
	<brief_summary>Ischemic postconditioning reduce myocardial injury follow myocardial infarction . A potential pharmacological agent anesthetic Sevoflurane . The investigator ' hypothesis sevoflurane primary percutaneous coronary intervention ( PCI ) reduce infarct size .</brief_summary>
	<brief_title>Sevoflurane In Acute Myocardial Infarction</brief_title>
	<detailed_description>Patients first STEMI treat primary PCI , randomize sedation Sevoflurane procedure usual care .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>First STEMI , present within 6 hour onset chest pain Symptoms lasting &gt; 30 minute Persistent STsegment elevation &gt; 0.1 mV 2 contiguous lead Hypersensitivity sevoflurane halogenated agent Malignant hyperthermia Cardiac arrest Cardiogenic shock Previous myocardial infarction coronary bypass surgery Preinfarction angina Heart failure ( NYHA III/IV ) Chronic inflammatory disease Severe renal impairment Hepatic dysfunction Use Glyburide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Acute myocardial infarction</keyword>
	<keyword>Postconditioning</keyword>
	<keyword>Sevoflurane</keyword>
</DOC>